Alnylam Pharmaceuticals, Inc.

MILLENNIUM MANAGEMENT LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

75,430

Value ($000)

29,995

Weight

0.0%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	29,995	0.0%	75,430	12/31/2025
2025 Q3	11/14/2025	250,769	0.2%	549,931	9/30/2025
2025 Q2	8/14/2025	29,493	0.0%	90,445	6/30/2025
2025 Q1	5/15/2025	77,587	0.1%	287,337	3/31/2025
2024 Q4	2/14/2025	78,462	0.1%	333,442	12/31/2024
2024 Q3	11/14/2024	69,022	0.1%	250,963	9/30/2024
2024 Q2	8/14/2024	33,656	0.0%	138,504	6/30/2024
2024 Q1	5/15/2024	30,230	0.0%	202,278	3/31/2024
2023 Q4	2/14/2024	6,993	0.0%	36,536	12/31/2023
2023 Q3	11/14/2023	2,853	0.0%	16,107	9/30/2023
2023 Q2	8/14/2023	14,242	0.0%	74,980	6/30/2023
2023 Q1	5/15/2023	4,682	0.0%	23,374	3/31/2023
2022 Q3	11/14/2022	34,582	0.0%	172,770	9/30/2022
2022 Q2	8/15/2022	649	0.0%	4,452	6/30/2022
2022 Q1	5/16/2022	10,444	0.0%	63,957	3/31/2022
2021 Q4	2/14/2022	14,146	0.0%	83,417	12/31/2021
2021 Q3	11/15/2021	2,234	0.0%	11,832	9/30/2021
2021 Q2	8/16/2021	1,716	0.0%	10,121	6/30/2021
2021 Q1	5/17/2021	10,699	0.0%	75,780	3/31/2021
2020 Q4	2/16/2021	15,641	0.0%	120,343	12/31/2020
2020 Q3	11/16/2020	757	0.0%	5,200	9/30/2020
2020 Q2	8/14/2020	646	0.0%	4,361	6/30/2020
2020 Q1	5/14/2020	10,969	0.0%	100,771	3/31/2020
2019 Q4	2/14/2020	13,620	0.0%	118,262	12/31/2019
2014 Q1	5/15/2014	8,551	0.0%	127,355	3/31/2014
2013 Q4	2/14/2014	348	0.0%	5,411	12/31/2013